Difficulty: Medium
Average Score: 83%
Practice
This drug weakly stimulates synthesis of very low density lipoproteins (VLDL):
Correct answer
A
Rationale
Correct Answer: A: Cholestyramine (Questran)
Rationale: Cholestyramine is a bile acid sequestrant that indirectly stimulates VLDL synthesis by interrupting enterohepatic circulation. It binds bile acids in the intestine, leading to increased hepatic cholesterol conversion to bile acids. This triggers compensatory upregulation of hepatic LDL and VLDL synthesis.
Summary of other choices:
B: Lovastatin (Mevacor) - Inhibits HMG-CoA reductase, reducing cholesterol synthesis.
C: Gemfibrozil (Lopid) - Increases lipoprotein lipase activity, reducing VLDL levels.
D: Probucol (Lorelco) - Reduces VLDL synthesis by inhibiting cholesterol ester transfer protein.
Rationale: Cholestyramine is a bile acid sequestrant that indirectly stimulates VLDL synthesis by interrupting enterohepatic circulation. It binds bile acids in the intestine, leading to increased hepatic cholesterol conversion to bile acids. This triggers compensatory upregulation of hepatic LDL and VLDL synthesis.
Summary of other choices:
B: Lovastatin (Mevacor) - Inhibits HMG-CoA reductase, reducing cholesterol synthesis.
C: Gemfibrozil (Lopid) - Increases lipoprotein lipase activity, reducing VLDL levels.
D: Probucol (Lorelco) - Reduces VLDL synthesis by inhibiting cholesterol ester transfer protein.